ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,402 | +0.6% | 1,471 | -6.8% | 0.00% | – |
| Q2 2023 | $84,868 | +334.3% | 1,579 | +220.9% | 0.00% | – |
| Q1 2023 | $19,540 | -18.7% | 492 | -18.0% | 0.00% | – |
| Q4 2022 | $24,023 | +71.6% | 600 | +37.0% | 0.00% | – |
| Q3 2022 | $14,000 | -17.6% | 438 | -24.1% | 0.00% | – |
| Q2 2022 | $17,000 | – | 577 | +4338.5% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 13 | -35.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -83.3% | 20 | -90.9% | 0.00% | – |
| Q4 2020 | $6,000 | -33.3% | 220 | -33.9% | 0.00% | – |
| Q3 2020 | $9,000 | -18.2% | 333 | +1.8% | 0.00% | – |
| Q2 2020 | $11,000 | -73.8% | 327 | -68.3% | 0.00% | – |
| Q1 2020 | $42,000 | – | 1,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |